Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 3
1965 16
1966 32
1967 39
1968 59
1969 50
1970 61
1971 61
1972 64
1973 58
1974 67
1975 79
1976 66
1977 85
1978 111
1979 115
1980 113
1981 123
1982 177
1983 160
1984 193
1985 230
1986 205
1987 236
1988 237
1989 279
1990 288
1991 278
1992 282
1993 327
1994 325
1995 330
1996 341
1997 315
1998 361
1999 392
2000 413
2001 481
2002 591
2003 606
2004 684
2005 792
2006 926
2007 1009
2008 1069
2009 1223
2010 1536
2011 1607
2012 1676
2013 1683
2014 1852
2015 1869
2016 1787
2017 1880
2018 1948
2019 2045
2020 2572
2021 2995
2022 3034
2023 2914
2024 1167

Text availability

Article attribute

Article type

Publication date

Search Results

39,811 results

Results by year

Filters applied: . Clear all
Page 1
Precision treatment in advanced hepatocellular carcinoma.
Yang X, Yang C, Zhang S, Geng H, Zhu AX, Bernards R, Qin W, Fan J, Wang C, Gao Q. Yang X, et al. Cancer Cell. 2024 Feb 12;42(2):180-197. doi: 10.1016/j.ccell.2024.01.007. Cancer Cell. 2024. PMID: 38350421 Review.
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma.
Llovet JM, Pinyol R, Yarchoan M, Singal AG, Marron TU, Schwartz M, Pikarsky E, Kudo M, Finn RS. Llovet JM, et al. Nat Rev Clin Oncol. 2024 Apr;21(4):294-311. doi: 10.1038/s41571-024-00868-0. Epub 2024 Feb 29. Nat Rev Clin Oncol. 2024. PMID: 38424197 Review.
Next-generation therapies for pancreatic cancer.
Buckley CW, O'Reilly EM. Buckley CW, et al. Expert Rev Gastroenterol Hepatol. 2024 Jan-Feb;18(1-3):55-72. doi: 10.1080/17474124.2024.2322648. Epub 2024 Feb 28. Expert Rev Gastroenterol Hepatol. 2024. PMID: 38415709 Review.
Advances in targeted therapy of cholangiocarcinoma.
Li Y, Yu J, Zhang Y, Peng C, Song Y, Liu S. Li Y, et al. Ann Med. 2024 Dec;56(1):2310196. doi: 10.1080/07853890.2024.2310196. Epub 2024 Feb 15. Ann Med. 2024. PMID: 38359439 Free PMC article. Review.
Neoadjuvant systemic therapy for hepatocellular carcinoma.
Chick RC, Ruff SM, Pawlik TM. Chick RC, et al. Front Immunol. 2024 Mar 1;15:1355812. doi: 10.3389/fimmu.2024.1355812. eCollection 2024. Front Immunol. 2024. PMID: 38495884 Free PMC article. Review.
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Chang YH, Lee JL, Sarwar N, Haas NB, Gurney H, Sawrycki P, Mahave M, Gross-Goupil M, Zhang T, Burke JM, Doshi G, Melichar B, Kopyltsov E, Alva A, Oudard S, Topart D, Hammers H, Kitamura H, McDermott DF, Silva A, Winquist E, Cornell J, Elfiky A, Burgents JE, Perini RF, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. N Engl J Med. 2024 Apr 18;390(15):1359-1371. doi: 10.1056/NEJMoa2312695. N Engl J Med. 2024. PMID: 38631003 Clinical Trial.
39,811 results
You have reached the last available page of results. Please see the User Guide for more information.